Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunomodulatory treatments and cognition in MS.
Neural Progenitor-Like Cells Induced From Human Gingiva-Derived Mesenchymal Stem Cells Regulate Myelination of Schwann Cells in Rat Sciatic Nerve Regeneration.
Prospective memory in multiple sclerosis: The impact of cue distinctiveness and executive functioning.
The organisation of physiotherapy for people with multiple sclerosis across Europe: a multicentre questionnaire survey.
Oligodendroglial deletion of ESCRT-I component TSG101 causes spongiform encephalopathy.
Fampridine and real-life walking in multiple sclerosis: Low predictive value of clinical test for habitual short-term changes.
Diffusion tensor imaging of occult injury of optic radiation following optic neuritis in multiple sclerosis.
14-3-3 proteins regulate K2P 5.1 surface expression on T lymphocytes.
Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
Administrative databases for observational studies in multiple sclerosis: power or peril?
The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.
The epidemiology of multiple sclerosis: insights to a causal cascade.
Reporting quality of randomized-controlled trials in multiple sclerosis from 2000 to 2015, based on CONSORT statement.
Clusterin CSF levels in differential diagnosis of neurodegenerative disorders.
Protocols for Cloning, Expression, and Functional Analysis of Sirtuin2 (SIRT2).
The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.
Humoral response against host-mimetic homologous epitopes of Mycobacterium avium subsp. paratuberculosis in Japanese multiple sclerosis patients.
Cortical demyelination can be modeled in specific rat models of autoimmune encephalomyelitis and is major histocompatibility complex (MHC) haplotype-related.
Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
A Bodybuilder With Weak Hands and Feet: Corticosteroid-Responsive Pure Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy Following Anabolic Steroid Use.
Recombinant soluble IFN receptor (sIFNAR2) exhibits intrinsic therapeutic efficacy in a murine model of Multiple Sclerosis.
Cerebral vasomotor reactivity in neurodegenerative diseases.
Personalised medicine for multiple sclerosis care.
No association of tobacco use and disease activity in multiple sclerosis.
Pages
« first
‹ previous
…
757
758
759
760
761
762
763
764
765
…
next ›
last »